New discoveries in chemical research and development in 2021. We’ll be discussing some of the latest developments in chemical about CAS: 22013-33-8, Recommanded Product: 22013-33-8, In a article, mentioned the application of 22013-33-8, molecular formula is C8H9NO2
The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer¿s disease, parkinson¿s disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.
The potential utility of systematic synthetic strategy will be applicable to efficient generations of chemical libraries of compounds to find ‘hit’ molecules.Read on for other articles about 22013-33-8 Recommanded Product: 22013-33-8